title: Modulation of alternative splicing of adenoviral E1A transcripts: factors involved in the early-to-late transition.
abstract: The E1A pre-mRNA of adenovirus is spliced into three mRNA species (13S, 12S, and 9S mRNAs) by the use of three alternative 5'-splice sites. The 13S and 9S mRNAs predominate during the early and late periods of infection, respectively. With HeLa nuclear extracts isolated in early and late periods of infection, we were able to reproduce a 13S-9S modulation that resembles that occurring in infected cells. An in vitro analysis of the cis-acting parameters involved in the 13S-9S switch indicates that the 13S mRNA splicing inhibition is one of the first events of the late period and leads to the subsequent stimulation of the 9S mRNA reaction. The new abilities of the late nuclear extract for the 9S mRNA reaction were also confirmed by analyzing splicing of a major late transcript containing leaders 1 and 2 separated by the wild-type intervening sequence (IVS) of 1021 nucleotides. Complementation experiments show that the trans-acting factor(s) are micrococcal nuclease sensitive. They were partially characterized by induction experiments, and we show that the primary factors responsible for the 13S-9S modulation in vitro are viral RNAs of high molecular weight that accumulate late in infection. We postulate that the splicing modulation of E1A pre-mRNA results from an indirect mode of action for these viral RNAs, based on a sequestration of common splicing factors that are not present in vast excess in HeLa cells.
authors.affiliation: Unité 184 de Biologie Moléculaire et de Génie Génétique de l'Institut National de la Recherche Médicale, Strasbourg, France.
authors.forename: R
authors.initials: R
authors.lastname: Gattoni
authors.forename: K
authors.initials: K
authors.lastname: Chebli
authors.forename: M
authors.initials: M
authors.lastname: Himmelspach
authors.forename: J
authors.initials: J
authors.lastname: Stévenin
mesh_terms: D000256:Adenoviridae / Q000235:genetics*; D017456:Adenovirus Early Proteins; D000957:Antigens, Viral, Tumor / Q000235:genetics; D001483:Base Sequence; D002467:Cell Nucleus / Q000502:physiology; D006367:HeLa Cells; D006801:Humans; D008969:Molecular Sequence Data; D009856:Oncogene Proteins, Viral / Q000235:genetics*; D010957:Plasmids; D012322:RNA Precursors / Q000235:genetics*; D012326:RNA Splicing; D012333:RNA, Messenger / Q000235:genetics*; D012367:RNA, Viral / Q000235:genetics*; D015183:Restriction Mapping; D013698:Templates, Genetic; D014158:Transcription, Genetic
chemical_list: D017456:Adenovirus Early Proteins; D000957:Antigens, Viral, Tumor; D009856:Oncogene Proteins, Viral; D012322:RNA Precursors; D012333:RNA, Messenger; D012367:RNA, Viral